First Allied Advisory Services Inc. lifted its holdings in shares of CME Group Inc (NASDAQ:CME) by 32.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,435 shares of the financial services provider’s stock after buying an additional 850 shares during the period. First Allied Advisory Services Inc.’s holdings in CME Group were worth $594,000 at the end of the most recent reporting period.
Other hedge funds have also modified their holdings of the company. Woodley Farra Manion Portfolio Management Inc. increased its holdings in shares of CME Group by 400.0% during the first quarter. Woodley Farra Manion Portfolio Management Inc. now owns 450 shares of the financial services provider’s stock valued at $78,000 after purchasing an additional 360 shares during the period. Oppenheimer & Co. Inc. grew its position in CME Group by 10.0% in the 1st quarter. Oppenheimer & Co. Inc. now owns 38,648 shares of the financial services provider’s stock valued at $6,683,000 after buying an additional 3,509 shares in the last quarter. Oppenheimer Asset Management Inc. increased its stake in CME Group by 3.1% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 25,388 shares of the financial services provider’s stock valued at $4,390,000 after buying an additional 764 shares during the period. Transcend Wealth Collective LLC raised its position in shares of CME Group by 3.8% during the 1st quarter. Transcend Wealth Collective LLC now owns 4,265 shares of the financial services provider’s stock worth $737,000 after buying an additional 157 shares in the last quarter. Finally, D L Carlson Investment Group Inc. acquired a new stake in shares of CME Group in the 1st quarter worth approximately $1,073,000. 85.08% of the stock is owned by institutional investors and hedge funds.
A number of research analysts recently commented on CME shares. Raymond James raised CME Group from a “market perform” rating to an “outperform” rating and set a $194.00 target price on the stock in a report on Monday, March 30th. Keefe, Bruyette & Woods cut CME Group from a “market perform” rating to an “underperform” rating in a research report on Sunday, April 19th. Oppenheimer restated a “buy” rating and issued a $216.00 price objective on shares of CME Group in a report on Tuesday, April 21st. Barclays reaffirmed a “buy” rating and set a $200.00 target price on shares of CME Group in a research note on Tuesday, April 14th. Finally, Wells Fargo & Co boosted their price target on shares of CME Group from $180.00 to $186.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 30th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $193.67.
CME Group (NASDAQ:CME) last released its earnings results on Wednesday, April 29th. The financial services provider reported $2.33 earnings per share for the quarter, topping the consensus estimate of $2.23 by $0.10. CME Group had a net margin of 45.79% and a return on equity of 10.15%. The business had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.48 billion. During the same period last year, the firm posted $1.62 earnings per share. The firm’s quarterly revenue was up 29.0% compared to the same quarter last year. Research analysts forecast that CME Group Inc will post 7.73 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Wednesday, June 10th will be given a dividend of $0.85 per share. This represents a $3.40 annualized dividend and a yield of 1.90%. The ex-dividend date is Tuesday, June 9th. CME Group’s payout ratio is 50.00%.
In other news, COO Julie Holzrichter sold 3,061 shares of the company’s stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $203.37, for a total value of $622,515.57. Following the transaction, the chief operating officer now owns 37,284 shares in the company, valued at approximately $7,582,447.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Julie Winkler sold 5,620 shares of the stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $210.97, for a total transaction of $1,185,651.40. Following the completion of the sale, the insider now directly owns 25,114 shares of the company’s stock, valued at $5,298,300.58. The disclosure for this sale can be found here. Over the last three months, insiders have sold 11,692 shares of company stock worth $2,350,147. Company insiders own 1.20% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Recommended Story: What factors cause inflation to rise?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.